FLT3 and acute myeloid leukemia: Relapsed FLT3-ITD AML patients had an increased FLT3-ITD/FLT3-WT ratio in blasts of bone marrow as well as other new abnormalities in cellular and molecular level, which may be related to the HR pathway activity after DSBs AML cells.